A 2011 chapter by Roland N. Auer on the histopathology of cerebral ischemia closed with four unresolved issues: which molecular cascades determine whether ischemic injury remains reversible, becomes selective neuronal necrosis, or progresses to infarction; whether apoptosis operates as a general mechanism of neuronal death in the adult ischemic brain; why specific brain regions and cell types are selectively vulnerable; and whether inflammatory responses are causal or secondary. Later work resolved the apoptosis sub-question by reframing it within regulated-cell-death biology, but the central fate-determination question, the mechanism of selective vulnerability, and the causal partition of inflammation remain open: 2025-2026 reviews still catalogue candidate, non-mutually-exclusive mechanisms and untranslated therapeutic targets.

Background

Cerebral ischemia interrupts oxygen and glucose delivery, collapsing ATP production and triggering the ischemic cascade: failure of ion pumps, glutamate release, and calcium influx through N-methyl-D-aspartate (NMDA) receptors (a glutamate-gated calcium channel), the process called excitotoxicity. The histopathological outcome varies: tissue may fully recover; may undergo selective neuronal necrosis, in which neurons die while glia and blood vessels survive; or may undergo pannecrosis (infarction), in which all cellular elements die and the tissue liquefies. The region between the necrotic core and normally perfused tissue, the ischemic penumbra, is the zone whose fate is genuinely undetermined and whose molecular determinants are sought. A striking feature, established with four-vessel occlusion models of transient global ischemia (occlusion of both vertebral and both carotid arteries; Pulsinelli and Brierley, 1979), is selective vulnerability: hippocampal CA1 pyramidal neurons, medium spiny neurons of the striatum, and cortical layers 3 and 5 die after insults that spare adjacent neurons, glia, and vasculature. The chapter of Auer (2011) synthesized the classical view that ischemic neurons die by an excitotoxic, acidosis-promoted necrotic process rather than by apoptosis (the genetically programmed, caspase-mediated cell-autonomous death of developmental biology), citing ultrastructural evidence against programmed cell death in global ischemia (Colbourne, Sutherland, and Auer, 1999) and cautions about the TUNEL stain (terminal deoxynucleotidyl transferase dUTP nick-end labeling, a DNA-break-labeling method), which cannot discriminate apoptosis from necrosis. It also reviewed the mixed early attempts to manipulate inflammation: antibodies against intercellular adhesion molecule 1 (ICAM-1), an endothelial adhesion molecule that recruits neutrophils to ischemic tissue, and neutrophil depletion reduced injury in some animal models but not others. Auer concluded that the field could not yet say which molecular cascades truly decide the histopathological outcome, why vulnerable regions succumb while neighbors survive, whether apoptosis operates as a general mechanism in the adult ischemic brain, or whether inflammatory pathways are causally contributory or merely secondary responses. Subsequent work transformed the conceptual vocabulary: regulated necrosis programs were discovered, including necroptosis (a death-receptor-triggered, kinase-regulated necrotic pathway involving receptor-interacting protein 1 (RIP1) kinase, identified through the necrostatin inhibitors by Degterev et al., 2008) and ferroptosis (an iron-dependent, lipid-peroxidation-driven death caused by failure of lipid-repair enzymes such as glutathione peroxidase 4 (GPX4), defined by Dixon et al., 2012). Parallel work reframed neuroinflammation, driven by microglia (the resident immune cells of the brain), infiltrating neutrophils and lymphocytes, and cytokines such as interleukin-1beta, as a time-dependent, dual-phase response that can both worsen early injury and support later repair (Iadecola and Anrather, 2011), while clinical anti-inflammatory neuroprotection failed, most strikingly when the anti-ICAM-1 antibody enlimomab worsened stroke outcome in humans (Enlimomab Acute Stroke Trial Investigators, 2001). The concept of the neurovascular unit (the functional ensemble of neurons, astrocytes, pericytes, and vascular cells) extended selective vulnerability from regions to cell types.

Problem Statement

Identify the molecular cascades that determine the histopathological fate of ischemic brain tissue — whether an ischemic insult in the adult brain remains reversible, proceeds to selective neuronal necrosis, or progresses to pannecrosis/infarction — addressing all three of the following, each requiring causal (intervention-based) validation: (1) which of the early biochemical changes (for example excitotoxic calcium loading, tissue acidosis, oxidative damage, and activation of regulated cell death programs such as necroptosis and ferroptosis) causally propagate to lasting tissue loss rather than being epiphenomenal; (2) the mechanistic basis of selective vulnerability, i.e. why specific regions and cell types (hippocampal CA1 pyramidal neurons, striatal medium spiny neurons, cortical layers 3 and 5, and the respective neurovascular-unit cell types) succumb while adjacent tissue survives the same insult; and (3) which inflammatory pathways are causally contributory to lesion progression versus secondary or repair-promoting responses, as a function of time after the insult. The companion sub-question posed by Auer's chapter — whether apoptosis operates as a general mechanism of neuronal death in the adult ischemic brain — has been substantially settled by the regulated-cell-death reframing (classical apoptosis is not the dominant mode) and is not part of the open core.

References

  1. Auer RN. Histopathology of Cerebral Ischemia. In: Stroke (Elsevier, ISBN 978-1-4160-5478-8), 2011, pp. 68-74. DOI: 10.1016/B978-1-4160-5478-8.10005-3. https://doi.org/10.1016/B978-1-4160-5478-8.10005-3
  2. Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979;10(3):267-272. DOI: 10.1161/01.STR.10.3.267. https://doi.org/10.1161/01.STR.10.3.267
  3. Colbourne F, Sutherland GR, Auer RN. Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia. The Journal of Neuroscience 1999;19(11):4200-4210. DOI: 10.1523/JNEUROSCI.19-11-04200.1999. https://doi.org/10.1523/JNEUROSCI.19-11-04200.1999
  4. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nature Chemical Biology 2008;4(5):313-321. DOI: 10.1038/nchembio.83. https://doi.org/10.1038/nchembio.83
  5. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 2012;149(5):1060-1072. DOI: 10.1016/j.cell.2012.03.042. https://doi.org/10.1016/j.cell.2012.03.042
  6. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nature Medicine 2011;17(7):796-808. DOI: 10.1038/nm.2399. https://doi.org/10.1038/nm.2399
  7. Enlimomab Acute Stroke Trial Investigators. Use of anti-ICAM-1 therapy in ischemic stroke. Neurology 2001;57:1428-1434. DOI: 10.1212/WNL.57.8.1428. https://doi.org/10.1212/WNL.57.8.1428
  8. Brookshier A, Lyden P. Differential vulnerability among cell types in the neurovascular unit: description and mechanisms. Journal of Cerebral Blood Flow and Metabolism 2025;45(1):3-12. DOI: 10.1177/0271678X241299960. https://doi.org/10.1177/0271678X241299960
  9. Kwak D, Park JH, Kim YH, Yoo HI. Decoding hippocampal subfield and glial responses in ischemia using single-cell transcriptomics. Journal of Translational Medicine 2025;23(1):671. DOI: 10.1186/s12967-025-06738-2. https://doi.org/10.1186/s12967-025-06738-2
  10. Duan Y, Yao L, Liang X, Xie Y, Gu X, Shen R. Neuroinflammation after stroke: initiation, amplification and therapeutic prospects. Journal of Translational Medicine 2026;24(1):700. DOI: 10.1186/s12967-026-08103-3. https://doi.org/10.1186/s12967-026-08103-3
  11. Bautista-Perez SM, Silva-Islas CA, Sánchez-Thomas R, Figueroa A, Barrera-Oviedo D, Maldonado PD. Targeting ferroptosis and necroptosis to treat stroke. Neurochemical Research 2026;51(2):135. DOI: 10.1007/s11064-026-04751-5. https://doi.org/10.1007/s11064-026-04751-5